Home › NDC Lookup › RxCUI directory › RxCUI 2053524

5 ML patisiran lipid complex 2 MG/ML Injection — RxCUI 2053524

RxNorm drug concept · Semantic clinical drug
RxCUI 2053524 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2053524
Official name5 ML patisiran lipid complex 2 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspatisiran lipid complex 10 MG per 5 ML Injection; patisiran lipid complex 10 MG in 5 mL Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 5 ML patisiran lipid complex 2 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 5 ML patisiran lipid complex 2 MG/ML Injection RxCUI 2053524

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Patisiran 2053490
    • Patisiran lipid complex 2284711
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Onpattro 2053525
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Patisiran Injection 2053523
    • Patisiran lipid complex Injection 2646515
    • Patisiran Injectable Product 2053522
    • Patisiran lipid complex Injectable Product 2660289
    • Patisiran Injection [Onpattro] 2053527
    • Patisiran lipid complex Injection [Onpattro] 2655035
    • Onpattro Injectable Product 2053528
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Patisiran lipid complex 2 MG/ML SCDC · 2284712
  • Patisiran Injection SCDF · 2053523
  • Patisiran lipid complex Injection SCDFP · 2646515
  • Patisiran Injectable Product SCDG · 2053522
  • Patisiran lipid complex Injectable Product SCDGP · 2660289

Brand-Name Concepts

  • 5 ML patisiran lipid complex 2 MG/ML Injection [Onpattro] SBD · 2053529
  • Patisiran lipid complex 2 MG/ML [Onpattro] SBDC · 2284714
  • Patisiran Injection [Onpattro] SBDF · 2053527
  • Patisiran lipid complex Injection [Onpattro] SBDFP · 2655035
  • Onpattro Injectable Product SBDG · 2053528
  • Onpattro BN · 2053525

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2053524 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71336-1000-01 1 VIAL, SINGLE-DOSE in 1 CARTON (71336-1000-1) / 5 mL in 1... Onpattro Alnylam Pharmaceuticals, Inc. 2018-08-13
Observed labelers: Alnylam Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0222 Inj., patisiran, 0.1 mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.